Zydus Lifesciences receives USFDA approval for Methenamine Hippurate tablets EP News Bureau Mar 12, 2025 Approval allows Zydus to manufacture and market 1-gram Methenamine Hippurate tablets in the United States
Glenmark launches Lacosamide Oral Solution, bioequivalent to Vimpat EP News Bureau Dec 16, 2024 Lacosamide Oral Solution, 10 mg/mL, enters the U.S. market with an annual market size of $57 million
